Skip to content
Subscriber Only
Business

Hong Kong Will Likely Resume BioNTech Shots Next Week: SCMP

People line up at a community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 10.

People line up at a community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 10.

Photographer: Lam Yik/Bloomberg
By

Hong Kong is likely to resume BioNTech-Pfizer vaccinations early next week, the South China Morning Post reported Wednesday, citing sources it didn’t identify.

Hong Kong was already struggling to raise its dismal vaccination rate when it halted the use of shots developed by BioNTech SE and Pfizer Inc. on March 24 after finding packaging defects in a small number of vials.